Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diederik De Cock

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Arthritis Care & Research|December 30, 2015
Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative StudyKristien van der Elst, Sabrina Meyfroidt, Diederik De Cock, et al.
Public Health|February 26, 2025
Needs and challenges of the payor and regulatory community towards integrating obesity into a chronic care frameworkLucas Schreurs, Jacqueline Bowman-Busato, Inge Gies, et al.
Clinical Rheumatology|March 14, 2020
Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCTVeerle Stouten, Stijn Michiels, René Westhovens, et al.
Rheumatology (Oxford, England)|April 13, 2022
New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritisSofia Pazmino, Anikó Lovik, Annelies Boonen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 22, 2024
The effect of physical activity on glycaemic control in people with type 1 diabetes mellitus: A systematic literature review and meta-analysisDiederik De Cock, Lucas Schreurs, Nele Steenackers, et al.
Rheumatology (Oxford, England)|October 3, 2017
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLucía Silva-Fernández, Diederik De Cock, Mark Lunt, et al.
Influenza and Other Respiratory Viruses|January 6, 2026
Longitudinal SARS-CoV-2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti-Spike IgG ImmunityEls Van Nedervelde, Ellen Vancutsem, Deborah De Geyter, et al.
International Journal of Obesity (2005)|June 20, 2024
Providing a common language for obesity: the European Association for the Study of Obesity obesity taxonomyJacqueline Bowman-Busato, Lucas Schreurs, Jason C G Halford, et al.
Annals of the Rheumatic Diseases|July 8, 2018
Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLianne Kearsley-Fleet, Rebecca Davies, Diederik De Cock, et al.
Clinical Rheumatology|August 9, 2022
Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trialMichaël Doumen, Delphine Bertrand, Sofia Pazmino, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Arthritis Care & Research|December 30, 2015
Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative StudyKristien van der Elst, Sabrina Meyfroidt, Diederik De Cock, et al.
Public Health|February 26, 2025
Needs and challenges of the payor and regulatory community towards integrating obesity into a chronic care frameworkLucas Schreurs, Jacqueline Bowman-Busato, Inge Gies, et al.
Clinical Rheumatology|March 14, 2020
Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCTVeerle Stouten, Stijn Michiels, René Westhovens, et al.
Rheumatology (Oxford, England)|April 13, 2022
New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritisSofia Pazmino, Anikó Lovik, Annelies Boonen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 22, 2024
The effect of physical activity on glycaemic control in people with type 1 diabetes mellitus: A systematic literature review and meta-analysisDiederik De Cock, Lucas Schreurs, Nele Steenackers, et al.
Rheumatology (Oxford, England)|October 3, 2017
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLucía Silva-Fernández, Diederik De Cock, Mark Lunt, et al.
Influenza and Other Respiratory Viruses|January 6, 2026
Longitudinal SARS-CoV-2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti-Spike IgG ImmunityEls Van Nedervelde, Ellen Vancutsem, Deborah De Geyter, et al.
International Journal of Obesity (2005)|June 20, 2024
Providing a common language for obesity: the European Association for the Study of Obesity obesity taxonomyJacqueline Bowman-Busato, Lucas Schreurs, Jason C G Halford, et al.
Annals of the Rheumatic Diseases|July 8, 2018
Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLianne Kearsley-Fleet, Rebecca Davies, Diederik De Cock, et al.
Clinical Rheumatology|August 9, 2022
Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trialMichaël Doumen, Delphine Bertrand, Sofia Pazmino, et al.
Pageof 8